Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-985-4 | CAS number: 68648-28-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2003
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced sprague dawley rat liver preparations (S9 mixture)
- Test concentrations with justification for top dose:
- 1, 10, 100, 1000, 10,000 and 100,000 µg/plate of the test substance (with and without S9 mix), a density of 1 gm/mL was cited for the test substance in the report. Test substance was tested neat and at 10, 100, 1000, 10000 and 100000 fold dilution in DMSO.
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Remarks:
- DMSO
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- N-ethyl-N-nitro-N-nitrosoguanidine
- other: 2-aminoanthracene
- Key result
- Species / strain:
- other: Salmonella typhimurium TA98, TAlOO, TA1535, TA1537 and Escherichia coli I WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic activity was observed
- Conclusions:
- Under the study conditions, the test substance was non-mutagenic with or without metabolic activation in the bacterial reverse mutation assay.
- Executive summary:
A study was conducted to determine the mutagenic potential of the test substance according to OECD Guideline 471, in compliance with GLP. The strains used were Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and Escherichia coli WP2. 1, 10, 100, 1000, 10,000 and 100,000 µg/plate of the test substance (with and without S9 mix), a density of 1 gm/mL was cited for the test substance in the report. Test material was tested neat and at 10, 100, 1000, 10000 and 100000 fold dilution in DMSO. The test substance was negative for mutagenic activity in the four Salmonella tester strains and in the E. coli strain, with or without metabolic activation. No mutagenic activity was observed at concentrations ranging from 1 µg/plate to the highest concentration of 100,000 µg/plate (neat). The bacterial strains tested included Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli strain WP2. The negative (vehicle) control and positive controls gave the appropriate responses as expected. Under the study conditions, the test substance was non-mutagenic with or without metabolic activation in the bacterial reverse mutation assay (US EPA HPV, 2004).
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2009
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- No data
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver microsomal enzyme homogenate
- Test concentrations with justification for top dose:
- 10, 33, 100, 333 and 1000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- for TA 1535
- Positive control substance:
- sodium azide
- Remarks:
- 5 µg/plate dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- for TA 98
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- 20 µg/plate dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- for TA 100
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- 650 µg/plate dissolved in DMSO
- Untreated negative controls:
- yes
- Remarks:
- ethanol
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- for WP2 uvrA
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- 10 µg/plate dissolved in DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- For the bacterial test with metabolic activation: TA1535, TA98 and TA100
- Positive control substance:
- other: 1 µg/plate 2-aminoanthracene dissolved in DMSO
- Remarks:
- none
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- For the bacterial test with metabolic activation: TA1537 and TA100
- Positive control substance:
- other: 2.5 µg/plate 2-aminoanthracene dissolved in DMSO
- Remarks:
- None
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- For the bacterial test with metabolic activation: TA1537
- Positive control substance:
- other: 5 µg/plate 2-aminoanthracene dissolved in DMSO
- Remarks:
- None
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Remarks:
- For the bacterial test with metabolic activation: WP2uvrA
- Positive control substance:
- other: 10 µg/plate 2-aminoanthracene dissolved in DMSO
- Remarks:
- None
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In agar (plate incorporation)
- Evaluation criteria:
- The negative control data (number of spontaneous revertants per plate) should be within the laboratory historical range for each tester strain. The positive control chemicals, sodium azide for TA1535; 9-aminoacridine for TA1537, 2-nitrofluorene for TA98, methylmethanesulphonate for TA100 and 4-nitroquinoline N-oxide for WP2uvrA should produce positive responses in all tester strains, which are within the laboratory historical range documented for each positive control substance. Furthermore, the mean plate count should be at least three times the concurrent vehicle control group means.
A test substance was considered negative (not mutagenic) in the test if (a) The total number of revertants in tester strain TA100 was not greater than
two times the concurrent control, and the total number of revertants in the tester strains TA1535, TA1537, TA98 or WP2uvrA was not greater than three times the concurrent control, (b) The negative response was reproducible in at least one independently repeated
experiment. - Statistics:
- Not applicable
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- COMPARISON WITH HISTORICAL CONTROL DATA: The negative and strain-specific positive control values were within the laboratory historical control data ranges.
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Under the conditions of the study, the test substance was considered to be non-mutagenic.
- Executive summary:
A study was conducted to determine the potential mutagenicity of glycerides, C16-18 and C18-unsatd. (in the fomr of pine nut oil), according to OECD Guideline 471, in compliance with GLP. Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA- were treated with the test substance using the Ames plate incorporation method at five dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The dose range was determined in a preliminary toxicity assay and was 3 to 5000 μg/plate. The experiment was repeated on using the same dose range as the range-finding test. The test substance caused a precipitation in the two highest concentration tested. The test substance was, therefore, tested up to the third dose level of 1000 μg/plate. No test substance precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test substance, either with or without metabolic activation. Under the conditions of the study, the test substance was considered to be non-mutagenic (Speijers, 2009).
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- In vitro mamammlian cell gene mutation tests using the thymidine kinase gene" following OECD 490
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 11, 2017 to July 03, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- OECD Guideline for the testing of chemicals, part 490, adopted July 26, 2016,”In vitro mammalian Cell gene mutation tests using the Thymidine Kinase Gene“
- Deviations:
- no
- Remarks:
- As all acceptability criteria of the assay were met or the deviations were considered as uncritical.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- EU-Method B.17 of the commission regulation (EC) no. 440/2008, adopted May 30, 2008,”In vitro mammalian Cell gene mutation test”
- Deviations:
- no
- Remarks:
- As all acceptability criteria of the assay were met or the deviations were considered as uncritical.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: In vitro mamammlian cell gene mutation tests using the thymidine kinase gene
- Specific details on test material used for the study:
- Name: Linseed oil, ester with pentaerythritol
Batch no.: 16.343.096
Appearance: Yellow liquid
Composition: 100% UVCB
Purity: 100% as the substance is an UVCB
Homogeneity: Homogeneous
Expiry date: October 05, 2017
Storage Room Temperature:(20 ± 5°C), After opening keep under inert gas - Target gene:
- Thymidine kinase gene
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- The L5178Y is a murine T-cell lymphoma cell line, which grows as single or aggregated
round cells in suspension. This cell line is characterized by a high sensitivity to chemical
mutagens, by a high proliferation rate (doubling time 10-12 h in stock cultures), a high
cloning efficiency (CE) and a stable spontaneous mutant frequency. The L5178Y consists
of a stable karyotype and shows a diploid chromosome number (40 ± 2). The cells were
purchased by ATCC (Wesel, Germany) and were sold under the name L5178Y TK+/-
clone (3.7.2C) [TK+/- (clone 3.7.2C)] (ATCC® CRL-9518™). - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver enzyme S9 fraction/liver S9 mix from male rats, treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Nominal concentrations in pre-test [μL/mL]: 5 2.5 1.25 0.63 0.31 0.16 0.08.
According to the OECD guideline 490 the highest concentration should be 0.01 M or 2 mg/mL or 2 μL/mL (whichever is lowest), unless limited by the solubility or toxicity of the test substance. RCE values below 20 % are considered toxic. In case of toxic effects, the highest test substance concentration of the main experiment should reduce the RSG value to 10 -20 %. In reference to the results of the pretest, 7-8 concentrations were chosen for experiment I and II:
Nominal concentrations in experiment I [μL/mL]: 2.5; 1.25; 0.63; 0.31; 0.16; 0.08; 0.04; 0.02
Nominal concentrations in experiment II [μL/mL]: 2.5; 0.63; 0.31; 0.16; 0.08; 0.04; 0.02 - Vehicle / solvent:
- In a non-GLP pre-test, the solubility of the test substance was determined. The test substance was sufficiently soluble in dimethyl sulfoxide (DMSO). Therefore, DMSO was used as solvent for the test substance.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- RPMI 1640 medium without supplements was used as solvent control for the positive control methyl methanesulfonate (MMS). 0.9% NaCl was used as solvent control for the positive control cyclophosphamide (CPA). DMSO was used as solvent for the test item.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Remarks:
- (1) Methyl methanesulfonate (MMS) (-S9) 19.5 μg/mL (Experiment I) and 12.5 μg/mL (Experiment II). (2) Cyclophosphamide (CPA) monohydrate (+S9) 4.5 μg/mL
- Details on test system and experimental conditions:
- Method of application: Test substance in DMSO
Incubation period: 4 h (Experiment I) and 24 h (Experiment II)
Number of replications: Two replicates per culture: Experiment I with 8 concentrations + Experiment II with 7 concentrations
Determination of genotoxicity method: Relative total growth (RTG) % and mutant per 106 cells
The TK is able to catalyse the conversion of the purine analogue Trifluorothymidine (TFT) to its cytostatic and cytotoxic derivative trifluorothymidine-monophosphate. Therefore, cells deficient in TK are resistant to TFT. These cells are able to proliferate in the presence of the chemical substance whereas the non-mutated cells die. However, the mutant phenotype requires a certain period of time before it is completely expressed. The phenotypic expression is achieved by allowing exponential growth of the cells for 48 ± 4 h. The mutant frequency is determined by cloning a known number of cells in 96-well plates containing the selective agent to detect mutant cells, and in 96-well plates without selective agent to determine the number of surviving cells (cloning efficiency). After a suitable period of time the colonies are counted. Mutation frequencies are calculated from the number of mutant colonies (growth in selective medium) divided by the number of surviving cells (non-selective medium). Furthermore the size of the colonies is evaluated. Despite the exact genetic reason for the different colony forms is not yet clear, it was postulated many times, that the induction of large mutant colonies is generally associated with chemicals inducing single point mutations and the induction of small-colony mutants with chemicals inducing massive chromosomal aberrations (Schisler et al., 2013). In the pre-test the cytotoxicity of the cells is given by the relative cloning efficiency, RCE of the cells. In the case of a clear reduction of the RCE value in comparison to the solvent control a readjustment of the tested concentrations should be made for the main experiments. In the main experiments the cytotoxicity was determined by the more exactly but also more complex relative total growth (RTG). Generally, RTG and RCE values below 20 % were defined as cytotoxic (Moore et al., 2002). In this case a determination of the mutation frequency is not valid. Reference mutagens are tested in parallel to the test substance in order to demonstrate the sensitivity of the test system. - Rationale for test conditions:
- Reasons for the Choice of the Cell Line L5178Y
The L5178Y is a murine T-cell lymphoma cell line, which grows as single or aggregated round cells in suspension. This cell line is characterized by a high sensitivity to chemical mutagens, by a high proliferation rate (doubling time 10-12 h in stock cultures), a high cloning efficiency (CE) and a stable spontaneous mutant frequency. The L5178Y consists of a stable karyotype and shows a diploid chromosome number (40 ± 2). - Evaluation criteria:
- Cell Numbers for Determination of RSG
- Cell numbers in suspension were determined with a cell counter. Afterwards, the total suspension growth (TSG) and the relative suspension growth (RSG) was calculated
Viability
- Number of empty wells per microwell plate was counted manually. All generated data of each experiment (test item, solvent controls and positive control) were recorded in the raw data. Afterwards the relative cloning efficiency (RCE) and the relative total growth (RTG) were calculated
Mutant Colonies
Colonies were counted manually under a binocular magnifying glass. In accordance with their size, the colonies were classified into two groups:
- Less than 25 % of the well’s diameter = small colony
- More than 25 % of the well’s diameter = large colony
All generated data of each experiment (test item, solvent controls and positive control) were recorded in the raw data. Afterwards the mutant frequency (MF) was calculated - Statistics:
- A linear regression (least squares) of the test substance concentrations was performed to assess a possible dose dependent increase of mutant frequencies. With the assessment of this regression, it can be evaluated whether mutations increase with increasing dose of the test substance. A p-value of 0.05 or lower (significance level 95%) is considered as critical. No significant correlation between the test substance concentrations and the mutant frequency was detected. The positive controls were tested at one concentration only. Therefore, no dose depend- ency could be evaluated, although the positive controls showed considerable increases in mutants. In the following table, the statistical significance values are presented. The chi- square test was used. Statistically significant increase in mutants is considered as given if p is below 0.01.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicty was observed for 0.63 and 2.5 μL/mL test substance concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Deviations from the study plan and guideline
In experiment I -S9, the TSG value in replicate B of the solvent control DMSO was 6.84% and therefore below 8%. The deviation is classified as uncritical, since it can be excluded that the end result is affected due to the slightly reduced growth rate in experiment I. In addition the mean of the two replicates was above 8. The deviation was assessed and signed by the study director on July 06, 2017.
In all experiments the RTG values of the cytotoxic test substance concentrations were not exactly between 10% and 20%. This deviation was considered as uncritical, since more important than a RTG value between 10-20% is, that a cytotoxic concentration occurs. In most cases, there is a point of turnover from complete cytotoxicity to low/moderate cytotoxicity. Therefore, a setting of such an exact RTG value is sometimes technically not possible. The deviation was assessed and signed by the study director on July 18, 2017. - Conclusions:
- Under the study conditions, the test substance did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, the test substance is considered to be nonmutagenic under the conditions of the mouse lymphoma assay.
- Executive summary:
A study was conducted to determine the genotoxic potential of the test substance, Linseed oil, ester with pentaerythritol, with the in vitro mammalian cell gene mutation tests using the thymidine kinase gene according to OECD Guideline 490, in compliance with GLP. This study was performed to investigate the potential of the test substance to induce mutations at the thymidine kinase locus (Tk1) on chromosome 11 and/or structural chromosomal aberrations in mouse lymphoma L5178Y Tk+/- cells. The assay was performed in a pre-test and three independent experiments whereby the first experiment I was declared invalid and was repeated with different concentrations. The results of the invalid experiment are not included in this final report. The pre-test was performed to detect a potential cytotoxic effect of the test substance. Based on the results of this test the concentrations for the two main experiments were determined. Experiment I was performed with and without metabolic activation (liver enzyme S9 fraction / “liver S9 mix from male rats, treated with Aroclor 1254”) and a treatment period of 4 h. Experiment II was performed with a treatment period of 24 h in the absence of metabolic activation. The highest nominal tested concentration was 2.5 μL/mL. Turbidity of the test substance was visible in all experimental parts at the test substance concentrations 2.5 μL/mL, 1.25 μL/mL, 0.63 μL/mL and 0.31 μL/mL. For that reason, in accordance to the OECD 490, the highest analyzable test substance concentration for mutagenicity is 0.31 μL/mL. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid. No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximum concentration of the test substance. Under the study conditions, the test substance did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, the test substance is considered to be nonmutagenic under the conditions of the mouse lymphoma assay (Fruhmesser, 2017).
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2003
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Arochlor 1254~induced Sprague-Dawly rat liver S9 mixture
- Test concentrations with justification for top dose:
- 0.05, 0.5 and 5 µL/mL (approx. 50, 500 and 5000 µg/ml based on a density of 1 g/mL)
- Untreated negative controls:
- yes
- Remarks:
- HHam’s F- 12 complete medium
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- Study was carried out to assess the ability of test substance to induce chromosomal aberrations in CHO cells cultured in vitro. Negative and positive control cultures were also prepared. One hour before the end of the incubation period, cell division was arrested with Colemid, the cells harvested and slides prepared so that the metaphase cells could be examined for chromosomal damage.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- Remarks:
- Ham’s F- 12 complete medium
- Positive controls validity:
- valid
- Remarks:
- mitomycin-C (-S9), cyclophosphamide (+S9)
- Additional information on results:
- The positive and negative controls gave the expected responses to fulfill the requirements of a valid test.
Negative control (Ham’s F- 12 complete medium) gave 1% aberrations with and without metabolic activation.
Positive control (cyclophosphamide) produced 18% aberrations in the metabolically activated CHO cell assay. Positive control (mitomycin C) produced 14% aberrations in the non-activated CHO cell assay. - Conclusions:
- Under the study conditions, the test substance was not clastogenic in the CHO cell culture test system
- Executive summary:
A study was conducted to assess the clastogenic properties of the test substance according to OECD Guideline 473, in compliance GLP. The test was carried out using Chinese hamster ovary (CHO) cells. The positive and negative controls gave the expected responses to fulfil the requirements of a valid test. Negative control (Ham’s F- 12 complete medium) gave 1% aberrations with and without metabolic activation. Positive control (cyclophosphamide) produced 18% aberrations in the metabolically activated CHO cell assay. Positive control (mitomycin C) produced 14% aberrations in the non-activated CHO cell assay. Regardless of dose level (from 0.05µL/mL to as high as 5µL/mL) and dosing regimen, the test substance was concluded to be negative for structural and numerical chromosome aberrations, with or without S-9. Under the study conditions, the test substance was not clastogenic in the CHO cell culture test system (US EPA HPV, 2004).
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From July 16, 1991 to July 27, 1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Strain S. typhimurium TA102 or E.coli WP2 were not tested.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- Strain S. typhimurium TA102 or E.coli WP2 not tested.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- His-operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: rfa-, uvR-, Strains 98 and 100 also R+
- Species / strain / cell type:
- S. typhimurium TA 1538
- Additional strain / cell type characteristics:
- other: rfa-, uvR-
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-Mix (Wistar rats, male, Aroclor 1254 induced)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- for strains TA 100 and TA 1535 without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 4-nitro-o-phenylendiamine
- Remarks:
- for strains TA 98 and TA 1538 without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- for strain TA 1537 without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- all strains with metabolic activation
- Key result
- Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Under the study conditions, the test substance was not considered to be mutagenic in the Salmonella typhimurium (strains TA 1535, TA 1537, TA 98 and TA 100 and TA 1538) reverse mutation assays.
- Executive summary:
A study was conducted to determine the mutagenic potential of the test substance Fatty acids, C16 -18 (even numbered), esters with pentaerythritol, was tested in a reverse mutation assay comparable to OECD guideline 471, in compliance with GLP. Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and TA 1538 were used. Tester strains were incubated with test material dissolved in Tween 80 at concentrations of 8, 40, 200, 1000 and 5000 µg/plate (no toxicity but tested up to precipitating concentrations) with and without the addition of a metabolic activation system (Aroclor 1254 induced rat liver S9-mix). Vehicle, negative and appropriate positive controls were included into the study design. Positive control materials induced statistically significant increases in the frequency of revertant colonies indicating the satisfactory performance of the test and the activity of the metabolizing system. No increase in the frequency of revertant colonies compared to concurrent controls was observed in all strains treated with the test substance, neither in the presence nor in the absence of metabolic activation. Under the study conditions, the test substance was not considered to be mutagenic in the Salmonella typhimurium (strains TA 1535, TA 1537, TA 98 and TA 100 and TA 1538) reverse mutation assays (BASF, 1991).
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From October 06, 2004 to February 16, 2004
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP - Guideline study. (Purity of test substance not given, evaluation criteria not given.)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- purity of test substance is not given (responsibility of the sponsor)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- Not applicable
- Species / strain / cell type:
- lymphocytes: cultured peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- -Type and identity of media: Eagles essential medium with HEPES buffer (MEM), supplemented with:
L-glutamine, penicillin/streptomycin, amphotericin B, 15% foetal calf serum
- Properly maintained: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- co-factor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats pretreated with phenobarbitone (80 mg/kg) and ß-naphtoflavone (100 mg/kg)
- Test concentrations with justification for top dose:
- Experiment I:
- 40, 80, 160, 240*, 320*, 400* µg/mL (with and without metabolic activation)
Experiment II:
- 40, 80, 160, 240*, 320*, 400* µg/mL (with and without metabolic activation)
* Dose levels (plus control dose) selected for metaphase analysis - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 h (with and without S9), 24 h (without)
- Fixation time (start of exposure up to fixation or harvest of cells): 4 h treatment: 20 h; 24 h treatment: 0 h
SPINDLE INHIBITOR (cytogenetic assays): Colcemid 0.1 µg/mL (demecolcine)
STAIN (for cytogenetic assays): 5% Gurrs Giemsa for 5 minutes
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 200 per culture
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index of 2000 cells
OTHER EXAMINATIONS:
- Determination of polyploidy: yes - Evaluation criteria:
- No data
- Statistics:
- The frequency of cells with aberrations excluding gaps and the frequency of polyploid cells was compared, where necessary, with the concurrent vehicle control value using Fisher's exact test.
- Key result
- Species / strain:
- lymphocytes: cultured peripheral human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: cloudy precipitates were observed at and above 40 and 80 µg/mL in the 24-hour continuous and 4-hour pulse treatment groups, respectively
RANGE-FINDING/SCREENING STUDIES:
The dose range tested was 10-320 µg/mL. The test material produced some weak toxicity in the 4-hour treatment group but not the 24-hour treatment group. Toxicity could not be reproduced in the main experiment (scorable metaphases at every dose level).
COMPARISON WITH HISTORICAL CONTROL DATA:
The results are in range with historical control data. - Conclusions:
- Under the study conditions, the test substance did not induce structural chromosome aberrations in the human lymphocytes with and without metabolic activation.
- Executive summary:
A study was conducted to determine in vitro cytogenicity of fatty acids, C16-18 and C18-unsatd., branched and linear ester with trimethylolpropane in cultured peripheral human lymphocyte study comparable to OECD Guideline 473, in compliance with GLP. Duplicate cultures of human lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation (rat liver S9-mix). In the first experiment cells were exposed for 4 h to the test substance dissolved in acetone at concentrations of 240, 320, 400 µg/mL with and without metabolic activation. In the second experiment cells were exposed for 4 h to 240, 320, 400 µg/mL with metabolic activation and for 24 h to 240, 320, 400 µg/mL followed by 24 h expression time without metabolic activation. The test substance did not induce cytotoxicity but a cloudy precipitate was already visible at 40 µg/mL. Vehicle (solvent) controls induced aberration frequencies within the range expected for normal human lymphocytes. Mitomycin C and cyclophosphamide were used as positive control substances inducing statistically significant increases in aberration frequencies indicating the satisfactory performance of the test and of the activity of the metabolizing system. Evaluation of 200 well-spread metaphase cells from each culture for structural chromosomal aberrations revealed no increase in the frequency of chromosome aberrations and polyploid cells at any dose level tested in comparison to the negative controls. The test substance was therefore considered to be non-clastogenic to human lymphocytes in vitro. Under the study conditions, the test substance did not induce structural chromosome aberrations in the human lymphocytes with and without metabolic activation (Arizona, 2004).
Referenceopen allclose all
Test results:
Exposure (h) | Metabolic activation | Doses tested (µL/mL) | Aberrations (%) at doses respectively | Test results |
2 | With | 0.05, 0.5 and 5 | 0.5, 1.0 and 3.0 | Negative |
18 | Without | 0.05, 0.5 and 5 | 0.0, 2.0 and 3.5 | Negative |
Table 1: Mutagenicity of glycerol triacetate on bacteria - experiment I
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
TA1538 |
TA98 |
TA1537 |
||
- |
Buffer |
116 |
9 |
10 |
22 |
7 |
Vehicle |
112 |
11 |
12 |
34 |
10 |
|
- |
8 |
114 |
10 |
7 |
29 |
10 |
- |
40 |
111 |
10 |
8 |
34 |
7 |
- |
200 |
114 |
8 |
9 |
29 |
8 |
- |
1000 |
120 |
12 |
7 |
25 |
6 |
- |
5000 |
132 |
6 |
9 |
29 |
6 |
Positive controls - S9 |
Name |
SA |
SA |
4NP |
4NP |
9AA |
Concentrations (μg/plate) |
2.0 |
2.0 |
40 |
40 |
80 |
|
Number of colonies/plate |
818 |
621 |
1792 |
1571 |
1025 |
|
+ |
Buffer |
116 |
11 |
15 |
38 |
6 |
+ |
Vehicle |
103 |
12 |
15 |
35 |
10 |
+ |
8 |
115 |
12 |
16 |
34 |
8 |
+ |
40 |
120 |
9 |
11 |
39 |
8 |
+ |
200 |
113 |
12 |
13 |
38 |
10 |
+ |
1000 |
126 |
11 |
14 |
39 |
7 |
+ |
5000 |
130 |
13 |
12 |
3934 |
7 |
Positive controls + S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5.0 |
2.5 |
5.0 |
5.0 |
2.5 |
|
Number of colonies/plate |
1594 |
210 |
1769 |
1572 |
66 |
4NP= 4-nitro-o-phenylendiamine
SA = Sodium azide
9AA = 9-Aminoacridine
2AA = 2-Aminoanthracene
Table 2: Mutagenicity of glycerol triacetate on bacteria - experiment II
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
TA1538 |
TA98 |
TA1537 |
||
- |
Buffer |
122 |
11 |
13 |
34 |
6 |
Vehicle |
127 |
13 |
9 |
39 |
13 |
|
- |
8 |
116 |
12 |
11 |
30 |
10 |
- |
40 |
110 |
14 |
12 |
31 |
8 |
- |
200 |
121 |
13 |
14 |
39 |
5 |
- |
1000 |
111 |
17 |
18 |
29 |
7 |
- |
5000 |
122 |
16 |
13 |
32 |
10 |
Positive controls - S9 |
Name |
SA |
SA |
4NP |
4NP |
9AA |
Concentrations (μg/plate) |
2.0 |
2.0 |
40 |
40 |
80 |
|
Number of colonies/plate |
1018 |
824 |
1929 |
1643 |
1017 |
|
+ |
Buffer |
127 |
15 |
19 |
40 |
9 |
+ |
Vehicle |
116 |
21 |
20 |
43 |
10 |
+ |
8 |
128 |
11 |
19 |
46 |
10 |
+ |
40 |
126 |
17 |
19 |
49 |
6 |
+ |
200 |
115 |
13 |
19 |
45 |
9 |
+ |
1000 |
121 |
19 |
16 |
49 |
10 |
+ |
5000 |
127 |
21 |
14 |
40 |
7 |
Positive controls + S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
5.0 |
2.5 |
5.0 |
5.0 |
2.5 |
|
Number of colonies/plate |
1535 |
327 |
1384 |
1515 |
64 |
4NP= 4-nitro-o-phenylendiamine
SA = Sodium azide
9AA = 9-Aminoacridine
2AA = 2-Aminoanthracene
Under the tested experimental conditions the test substance did not induce gene mutations in S. typhimurium strains up to the maximum of solubility. Therefore it is not considered to be mutagenic in this bacterial mutagenicity test in vitro.
Test results of experiment I.
Test item |
Concentration |
Mitotic Index |
Aberrant cells in % |
|
Experiment I |
in µg/mL |
in % |
with gaps |
without gaps |
Exposure period 4h, fixation time 20h, without S9 mix |
||||
control |
0 |
100 |
1 |
0 |
MMC |
0.4 |
35 |
53 |
37 |
Test substance |
240 |
98P |
0.5 |
0 |
320 |
110P |
0 |
0 |
|
400 |
91P |
0.5 |
0.5 |
|
Exposure period 4h, fixation time 20h, with S9 mix |
||||
control |
0 |
100 |
1 |
0.5 |
CP |
10 |
20 |
35.5 |
28.5 |
Test substance |
240 |
89P |
1.5 |
0 |
320 |
89P |
0.5 |
0 |
|
400 |
108P |
3.5 |
1 |
Test item |
Concentration |
Mitotic Index |
Aberrant cells in % |
|
Experiment II |
in µg/mL |
in % |
with gaps |
without gaps |
Exposure period + fixation time 24h, without S9 mix |
||||
control |
0 |
100 |
1.5 |
0 |
MMC |
0.4 |
41 |
70 |
67 |
Test substance |
240 |
61 |
0.5 |
0.5 |
320 |
53 |
0.5 |
0 |
|
400 |
83 |
0 |
0 |
|
Exposure period 4h, fixation time 20h, with S9 mix |
||||
control |
0 |
100 |
0.5 |
0 |
CP |
10 |
30 |
67 |
56 |
Test substance |
240 |
103 |
1 |
0 |
320 |
76 |
1 |
0 |
|
400 |
110 |
1.5 |
0.5 |
Mean Frequency of Polyploid Cells (%)
Experiment I dose level µg/mL |
harvest time 24 hours |
|
4 hours without S9 |
4 hours with S9 |
|
0 |
0.0 |
0.0 |
240 |
0.0 |
0.0 |
320 |
0.0 |
0.0 |
400 |
0.0 |
0.0 |
MMC 0.4 |
0.0 |
NA |
CP 10 |
NA |
0.0 |
dose level µg/mL |
harvest time 24 hours |
|
24 hours without S9 |
4 hours with S9 |
|
0 |
0.5 |
0.0 |
240 |
0.0 |
0.0 |
320 |
0.0 |
0.0 |
400 |
0.0 |
0.5 |
MMC 0.4 |
0.0 |
NA |
CP 10 |
NA |
0.0 |
CP: Cyclophosphamide
MMC: Mitomycin C
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Genetic toxicity was assessed based on toxicity studies for the test substance itself, but also on substances representative of the main constituents, which can be categorised as pentaerythritol esters (PE) and glycerol esters (GE). The results are presented below:
In vitro gene mutation study in bacteria (Ames test)
Linseed oil, ester with pentaerythritol
A study was conducted to determine the mutagenic potential of the test substance according to OECD Guideline 471, in compliance with GLP. The strains used were Salmonella typhimurium TA 1535, TA 1537, TA 98, TA 100 and Escherichia coli WP2. 1, 10, 100, 1000, 10,000 and 100,000 µg/plate of the test substance (with and without S9 mix), a density of 1 gm/mL was cited for the test substance in the report. Test material was tested neat and at 10, 100, 1000, 10000 and 100000 fold dilution in DMSO. The test substance was negative for mutagenic activity in the four Salmonella tester strains and in the E. coli strain, with or without metabolic activation. No mutagenic activity was observed at concentrations ranging from 1 µg/plate to the highest concentration of 100,000 µg/plate (neat). The bacterial strains tested included Salmonella typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli strain WP2. The negative (vehicle) control and positive controls gave the appropriate responses as expected. Under the study conditions, the test substance was non-mutagenic with or without metabolic activation in the bacterial reverse mutation assay (US EPA HPV, 2004).
Pentaerythritol esters (PE)
A study was conducted to determine the mutagenic potential of fatty acids, C16-18 (even numbered), esters with pentaerythritol in a reverse mutation assay comparable to OECD Guideline 471, in compliance with GLP. Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and TA 1538 were used. Tester strains were incubated with test material dissolved in Tween 80 at concentrations of 8, 40, 200, 1000 and 5000 µg/plate (no toxicity but tested up to precipitating concentrations) with and without the addition of a metabolic activation system (Aroclor 1254 induced rat liver S9-mix). Vehicle, negative and appropriate positive controls were included into the study design. Positive control materials induced statistically significant increases in the frequency of revertant colonies indicating the satisfactory performance of the test and the activity of the metabolizing system. No increase in the frequency of revertant colonies compared to concurrent controls was observed in all strains treated with the test substance, neither in the presence nor in the absence of metabolic activation. Under the study conditions, the test substance was not considered to be mutagenic in the Salmonella typhimurium (strains TA 1535, TA 1537, TA 98 and TA 100 and TA 1538) reverse mutation assay (BASF, 1991).
Glycerol esters (GE)
A study was conducted to determine the potential mutagenicity of glycerides, C16-18 and C18-unsatd. (in the fomr of pine nut oil), according to OECD Guideline 471, in compliance with GLP. Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA- were treated with the test substance using the Ames plate incorporation method at five dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The dose range was determined in a preliminary toxicity assay and was 3 to 5000 μg/plate. The experiment was repeated on using the same dose range as the range-finding test. The test substance caused a precipitation in the two highest concentration tested. The test substance was, therefore, tested up to the third dose level of 1000 μg/plate. No test substance precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9-mix. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test substance, either with or without metabolic activation. Under the conditions of the study, the test substance was considered to be non-mutagenic (Speijers, 2009).
In vitro chromosomal aberration test
Linseed oil, ester with pentaerythritol
A study was conducted to assess the clastogenic properties of the test substance according to OECD Guideline 473, in compliance GLP. The test was carried out using Chinese hamster ovary (CHO) cells. The positive and negative controls gave the expected responses to fulfil the requirements of a valid test. Negative control (Ham’s F- 12 complete medium) gave 1% aberrations with and without metabolic activation. Positive control (cyclophosphamide) produced 18% aberrations in the metabolically activated CHO cell assay. Positive control (mitomycin C) produced 14% aberrations in the non-activated CHO cell assay. Regardless of dose level (from 0.05µL/mL to as high as 5µL/mL) and dosing regimen, the test substance was concluded to be negative for structural and numerical chromosome aberrations, with or without S-9. Under the study conditions, the test substance was not clastogenic in the CHO cell culture test system (US EPA HPV, 2004).
Pentaerythritol esters (PE)
A study was conducted to determine in vitro cytogenicity of fatty acids, C16-18 and C18-unsatd., branched and linear ester with trimethylolpropane in cultured peripheral human lymphocyte study comparable to OECD Guideline 473, in compliance with GLP. Duplicate cultures of human lymphocytes were evaluated for chromosome aberrations in the presence and absence of metabolic activation (rat liver S9-mix). In the first experiment cells were exposed for 4 h to the test substance dissolved in acetone at concentrations of 240, 320, 400 µg/mL with and without metabolic activation. In the second experiment cells were exposed for 4 h to 240, 320, 400 µg/mL with metabolic activation and for 24 h to 240, 320, 400 µg/mL followed by 24 h expression time without metabolic activation. The test substance did not induce cytotoxicity but a cloudy precipitate was already visible at 40 µg/mL. Vehicle (solvent) controls induced aberration frequencies within the range expected for normal human lymphocytes. Mitomycin C and cyclophosphamide were used as positive control substances inducing statistically significant increases in aberration frequencies indicating the satisfactory performance of the test and of the activity of the metabolizing system. Evaluation of 200 well-spread metaphase cells from each culture for structural chromosomal aberrations revealed no increase in the frequency of chromosome aberrations and polyploid cells at any dose level tested in comparison to the negative controls. The test substance was therefore considered to be non-clastogenic to human lymphocytes in vitro. Under the study conditions, the test substance did not induce structural chromosome aberrations in the human lymphocytes with and without metabolic activation (Arizona, 2004).
In vitro mammalian mutation test
Linseed oil, ester with pentaerythritol
A study was conducted to determine the genotoxic potential of the test substance in an in vitro mammalian cell gene mutation tests using the thymidine kinase gene according to OECD Guideline 490, in compliance with GLP. This study was performed to investigate the potential of the test substance to induce mutations at the thymidine kinase locus (Tk1) on chromosome 11 and/or structural chromosomal aberrations in mouse lymphoma L5178Y Tk+/- cells. The assay was performed in a pre-test and three independent experiments whereby the first experiment I was declared invalid and was repeated with different concentrations. The results of the invalid experiment are not included in this final report. The pre-test was performed to detect a potential cytotoxic effect of the test substance. Based on the results of this test the concentrations for the two main experiments were determined. Experiment I was performed with and without metabolic activation (liver enzyme S9 fraction / “liver S9 mix from male rats, treated with Aroclor 1254”) and a treatment period of 4 h. Experiment II was performed with a treatment period of 24 h in the absence of metabolic activation. The highest nominal tested concentration was 2.5 μL/mL. Turbidity of the test substance was visible in all experimental parts at the test substance concentrations 2.5 μL/mL, 1.25 μL/mL, 0.63 μL/mL and 0.31 μL/mL. For that reason, in accordance to the OECD 490, the highest analyzable test substance concentration for mutagenicity is 0.31 μL/mL. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid. No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximum concentration of the test substance. Under the study conditions, the test substance did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, the test substance is considered to be non-mutagenic under the conditions of the mouse lymphoma assay (Fruhmesser, 2017).
In vivo genotoxicity
Glycerol esters (GE)
A study was conducted to evaluate possible clastogenic and cytotoxic activity of glycerides, C16-18 and C18-unsatd. (in the form of red palm oil) in mouse bone marrow cells in vivo. Three groups of Balb/C female mice, 10 per group, were dosed with test substance supernatant, test substance sediment or a mixture of the two at a dose level of 4500 mg/kg bw/d by gavage for 5 consecutive days. A negative group was dosed (by gavage) with corn oil and the positive control group was injected intraperitoneally with cyclophosphamide. 24 h after the last treatment each animal were killed by cervical dislocation. The femurs from each animal were dissected and stripped clean of muscles, for cytological preparations from bone marrow. For each animal 100 bone marrow metaphase cells were analysed for evaluation of chromosome aberration and 1000 cells for determination of mitotic index. No statistically significant differences were observed in the frequency of chromosomal aberrations and the mitotic index in bone marrow samples in any of the three groups. Under the study conditions, test substance did not induce chromosomal aberrations in mouse bone marrow cells, in vivo, after daily expositions of 4500 mg/kg bw/d. Furthermore, this dose did not promote any alteration in the mitotic index, suggesting that test substance had no cytotoxic effects (Oliveria, 1994).
Justification for classification or non-classification
Based on the information available for the substance itself and/or its main constituents, the test substance is not considered to meet the requirements for genetic toxicity classification according to the EU CLP (Regulation 1272/2008/EC) criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.